Friedrich Luft zum Ehrendoktor der Friedrich-Alexander-Universität Erlangen-Nürnberg ernannt

Friedrich Luft receives honorary doctorate from FAU

Salt and blood are the two substances to which he has dedicated his research career: Professor Friedrich C. Luft, who heads a lab at the Max Delbrück Center for Molecular Medicine (MDC), has been conferred an honorary doctorate by the Faculty of Medicine of Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU).

The collaboration between Friedrich Luft and FAU goes back three decades. “Professor Friedrich Luft has helped put the nephrology department at Friedrich-Alexander-Universität Erlangen-Nürnberg on the international map, and he continues to be involved in nephrological-hypertension research in Erlangen up to this day. For many years now, he has also advocated vehemently and with great commitment for improving the training and career paths of young clinicians. Moreover, he has contributed essential knowledge on the genetic forms of hypertension through, among other things, his meticulous clinical observations,” said Professor Kerstin Amann, head of the Department of Nephropathology at Universitätsklinikum Erlangen, in her laudatory speech at the ceremony on July 25 conferring the Doctor of Medicine honoris causa on Friedrich Luft. This is the second honor of this kind for Professor Luft, who also received an honorary doctorate from the University of Pécs in 2002.

In 1989 Friedrich Luft accepted a professorship in Erlangen, but already in 1992 he joined the newly established MDC in Berlin. His work, however, is in many ways closely connected with the Bavarian university. He carried out one of his most important studies with a young physician from Erlangen’s children’s hospital. It was conducted mainly on the Black Sea coast in northeast Turkey. Half of the members of a large family suffered from a rare form of hypertension, which is genetically linked to brachydactyly (abnormally short fingers or toes). That was in 1994; in 2015 Friedrich Luft and his team at the ECRC succeeded in identifying the mutated enzyme responsible for the disease. This research, which is overseen by Friedrich-Alexander-Universität Erlangen-Nürnberg, still continues today. Two animal models, which will soon be published and could lead to new treatments, have since been created in collaboration with MDC researchers.

Physician and researcher

Another central research focus of Friedrich Luft is the body’s salt balance and its effect on cardiovascular diseases. This topic is also closely connected with Friedrich-Alexander-Universität Erlangen-Nürnberg, for Luft started working on this topic in 2000 on the suggestion of FAU professor Jens Titze. Together they discovered a previously unknown mechanism for storing sodium chloride in the skin, and that its impairment causes hypertension. A few years ago, the two researchers and their teams were able to show that a high salt intake may not be as harmful as long believed.

Friedrich C. Luft was born in Berlin in 1942. He studied zoology at Colorado College in Colorado Springs and medicine at Thomas Jefferson University in Philadelphia, where he earned his doctorate in 1968. From 1975 to 1989 he was a professor in the Department of Nephrology and Intensive Medicine at the Indiana University School of Medicine in Indianapolis in the United States. At the MDC Friedrich Luft set up a research group focusing on the molecular genetics of cardiovascular diseases, and from 1993 to 2010 he was also chief physician in the Department of Internal Medicine and Nephrology at the Franz Volhard Clinic. In 2007 he was appointed director of the newly founded ECRC, which he headed until 2018. Professor Luft received the Richard Bright Award of the American Society of Hypertension in 2004, and three years later he was honored with the Hypertension Research Award of the American Heart Association and with the Franz Volhard Medal of the German Society for Nephrology. In 2008 the medical students of Charité bestowed on him the Lehrbär for his outstanding teaching. The physician still heads his research group. It mainly investigates the special form of hypertension that Professor Luft has now been studying for a quarter-century.

He had this to say about the honorary doctorate from FAU: “I am very pleased to be recognized in this way. It has always been very important for me to get young people excited about medical research, and I have succeeded in doing just that in both Erlangen and Berlin. The programs I started back then are still running today.”

Text: Wiebke Peters

 

Further Information

Der Arzt des MDC

Die Arbeitsgruppe von Friedrich Luft

Der Clinical Journal Club

Contact 

Jana Schlütter
Editor, Communications Depratment
Max Delbrück Center for Molecular Medizine in the Helmholtz Association (MDC)

+49-30-9406-2121
jana.schluetter@mdc-berlin.de

The Max Delbrück Center for Molecular Medicine (MDC)

 

The Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC) was founded in Berlin in 1992. It is named for the German-American physicist Max Delbrück, who was awarded the 1969 Nobel Prize in Physiology and Medicine. The MDC's mission is to study molecular mechanisms in order to understand the origins of disease and thus be able to diagnose, prevent and fight it better and more effectively. In these efforts the MDC cooperates with the Charité - Universitätsmedizin Berlin and the Berlin Institute of Health (BIH ) as well as with national partners such as the German Center for Cardiovascular Research and numerous international research institutions. More than 1,600 staff and guests from nearly 60 countries work at the MDC, just under 1,300 of them in scientific research. The MDC is funded by the German Federal Ministry of Education and Research (90 percent) and the State of Berlin (10 percent), and is a member of the Helmholtz Association of German Research Centers. www.mdc-berlin.de